Company Filing History:
Years Active: 2019
Title: Roberta Cozzi: Innovator in Immunology
Introduction
Roberta Cozzi is a distinguished inventor based in Siena, Italy. She has made significant contributions to the field of immunology, particularly through her innovative work on carrier molecules for antigens. Her research has the potential to enhance vaccine development and improve immune responses in mammals.
Latest Patents
Roberta holds a patent for a conjugate that comprises an antigen and a carrier molecule. This invention specifically includes a BP-2a antigen and a spb1 antigen. The conjugate is designed to be used in methods for raising an immune response in mammals, which involves administering the conjugate to the mammal. Additionally, her patent encompasses pharmaceutical compositions, particularly vaccines, that utilize this conjugate.
Career Highlights
Roberta Cozzi is currently employed at GlaxoSmithKline Biologicals SA, where she continues to advance her research in immunology. Her work is characterized by a commitment to developing innovative solutions that can lead to improved health outcomes.
Collaborations
Roberta has collaborated with notable colleagues in her field, including Francesco Berti and Domenico Maione. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Roberta Cozzi's contributions to immunology through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work promises to make a significant impact on vaccine development and immune response enhancement.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.